trending Market Intelligence /marketintelligence/en/news-insights/trending/KMmfhztzQbkIpoEa85AILQ2 content esgSubNav
In This List

Integra increases credit facility to fund acquisition of J&J's neurosurgery biz

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Integra increases credit facility to fund acquisition of J&J's neurosurgery biz

Integra LifeSciences Holdings Corp. increased its credit facility to finance the acquisition of Johnson & Johnson's Codman Neurosurgery business.

The medical technology company will be borrowing an extra $700 million from its bank group led by Bank of America NA, expanding the credit facility to $2.2 billion from $1.5 billion.

The $700 million term loan will be available in a single drawing on a delayed basis, upon closing of the acquisition.

The acquisition is expected to close in the fourth quarter, Integra CFO Glenn Coleman said in the news release.

The credit facility, comprising the expanded term loan of $1.2 billion and revolving credit of $1 billion, matures Dec. 7, 2021.